STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Stryker Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Stryker Corp (SYK) Form 4: VP & Chief Communications Officer Kimberly Ann Montagnino had 155 common shares withheld on 01-Aug-2025 (transaction code “F”) at $392.73 to cover tax liabilities on vested equity. Post-withholding, the executive still owns 1,195 shares directly and 13 shares indirectly through a 401(k). No derivative positions or additional trades were reported, and the filing does not cite a Rule 10b5-1 trading plan. Given the small size and tax-related nature, this insider activity is considered routine and unlikely to influence SYK’s valuation.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-related share withholding; negligible effect on ownership structure or investor sentiment.

The “F” code signifies shares surrendered to satisfy withholding taxes upon vesting of prior equity awards, not an open-market sale. At roughly $392.73 per share, the dollar value is about $61k—immaterial relative to Stryker’s daily trading volume and the executive’s remaining stake (≈$470k). No derivatives, 10b5-1 plan, or multiple insiders were involved, reinforcing the low signaling value. I view the filing as neutral with no actionable implication for investors.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Montagnino Kimberly Ann

(Last) (First) (Middle)
1941 STRYKER WAY

(Street)
PORTAGE MI 49002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Chief Comm. Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 F 155 D $392.73 1,195 D
Common Stock 13 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Austin Y. Ke, attorney-in-fact for Kimberly Ann Montagnino 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stryker (SYK) disclose in the latest Form 4?

A VP had 155 shares withheld at $392.73 on 01-Aug-2025 for tax purposes, retaining 1,195 direct shares.

Was the insider activity an open-market sale?

No. Code “F” shows shares were surrendered to cover taxes on vested equity, not sold on the market.

How many Stryker shares does the executive still own?

After the transaction, she holds 1,195 shares directly and 13 shares indirectly via a 401(k).

Did the filing mention any derivative securities?

No derivative securities were reported in Table II.

Is the transaction likely to impact SYK stock price?

Given its small size and routine nature, analysts consider the impact negligible.
Stryker Corp

NYSE:SYK

SYK Rankings

SYK Latest News

SYK Latest SEC Filings

SYK Stock Data

137.86B
361.55M
5.36%
81.68%
1.09%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PORTAGE